BATON ROUGE, La., Oct. 2, 2024 /PRNewswire/ -- Ambetter from Louisiana Healthcare Connections, a product offered by a Centene Corporation (NYSE: CNC) company, which provides insurance to under-insured and uninsured populations through the federal Health Insurance Marketplace®, will offer a variety of affordable health insurance plans to Louisianans in 22 parishes for plan year 2025. Open enrollment for the Health Insurance Marketplace in Louisiana runs from Nov. 1, 2024, through Jan. 15, 2025. Enroll by Dec. 15 for coverage starting Jan. 1, 2025.
"We are honored to bring our affordable healthcare solutions to even more Louisianans in the year to come," said Jamie Schlottman, Louisiana Healthcare Connections plan president and CEO. "With Ambetter from Louisiana Healthcare Connections plans, members can rely on accessible and convenient care that provides the coverage and support they need."
Ambetter from Louisiana Healthcare Connections offers its members access to quality care, convenient services and valuable rewards. The 2025 benefits and offerings include:
Below is the full list of parishes in which Ambetter from Louisiana Healthcare Connections will be offered in 2025:
Louisiana residents interested in learning more about Ambetter from Louisiana Healthcare Connections or enrolling in a health plan during the open enrollment period may visit ambetterhealth.com/en/la.
About Ambetter from Louisiana Healthcare Connections
Ambetter from Louisiana Healthcare Connections serves under-insured and uninsured populations through the federal Health Insurance Marketplace®. Ambetter from Louisiana Healthcare Connections is underwritten by Ambetter Health of Louisiana, Inc., which is a Qualified Health Plan issuer in Louisiana. For more information, visit ambetterhealth.com/en/la. This is a solicitation for insurance. For information on your right to receive an Ambetter from Louisiana Healthcare Connections plan free of discrimination, or your right to receive language, auditory and/or visual assistance services, please visit ambetterhealth.com/en/ and scroll to the bottom of the page.
Last Trade: | US$63.36 |
Daily Change: | -0.46 -0.72 |
Daily Volume: | 112,005 |
Market Cap: | US$33.330B |
October 30, 2024 October 25, 2024 September 11, 2024 August 29, 2024 |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORECue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB